• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Pfiz­er scores high­est spend­ing dur­ing NFL sea­son among phar­ma ad­ver­tis­ers — iS­pot analy­sis

3 years ago
Pharma
Marketing

Amid ap­pli­ca­tion tsuna­mi, FDA's top cell and gene ther­a­py leader to re­tire in March

3 years ago
People
FDA+

Pan­dem­ic wait is over: FDA be­gins tran­si­tion to in-per­son meet­ings in March

3 years ago
FDA+

Covid pub­lic health emer­gen­cies to end in May, but FDA's EUA au­thor­i­ty will con­tin­ue

3 years ago
Pharma
FDA+

Mar­ket­ingRx roundup: Pub­li­cis takes can­cer work­place ef­fort to Su­per Bowl; Phar­ma ad­ver­tis­ers still spend big on TV

3 years ago
Pharma
Marketing

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

3 years ago
Financing
Startups

Q&A: No­vo Nordisk mar­ket­ing chief aims to change the con­ver­sa­tion around obe­si­ty, even as so­ci­ety has its own plans

3 years ago
Pharma
Marketing

Sen­so­ri­on part­ners on in­jec­tion sys­tem for ther­a­py de­liv­ery; Kymera and X-Chem ex­pand deal

3 years ago
News Briefing

No­var­tis' Xo­lair suc­ces­sor hit by an­oth­er PhI­II axe, but food al­ler­gy study con­tin­ues

3 years ago
R&D
Pharma

Gilead quash­es mi­cro­cap biotech's hope of part­ner­ing on oral Covid-19 drug

3 years ago
Deals

UniQure cash­es out $10M up­front to get can­di­date for in­her­it­ed ALS

3 years ago
Deals

Pfiz­er cuts eight pro­grams, in­clud­ing dwarfism drug at cen­ter of Ther­a­chon buy­out

3 years ago
R&D

Small Ne­bras­ka start­up hopes to chal­lenge Pfiz­er, Mer­ck in pneu­mo­coc­cal vac­cine race

3 years ago
Startups
R&D

In­ovio’s decades of shift­ing ex­tends to way­ward win­ter in pipeline, work­force thin­ning 

3 years ago
People
R&D

New York City in­vests $20M in­to biotech 'in­no­va­tion space' at the Brook­lyn Navy Yard

3 years ago
Startups
R&D

Am­gen launch­es the first US Hu­mi­ra biosim­i­lar at two dif­fer­ent list prices

3 years ago
Pharma

Af­ter piv­ot­ing from Alzheimer's to bone con­di­tions, biotech piv­ots again — and halves its head­count

3 years ago
People
Deals

Boehringer In­gel­heim touts pre­ven­tion re­sults in rarest form of pso­ri­a­sis

3 years ago
R&D
Pharma

As­traZeneca, No­vo Nordisk and Sanofi score 340B-re­lat­ed ap­peals court win over HHS

3 years ago
Pharma
Law

Roche’s Genen­tech de­buts next it­er­a­tion of MS cam­paign, high­lights ex­pe­ri­ences in Black com­mu­ni­ty

3 years ago
Pharma
Marketing

IRA's price ne­go­ti­a­tion pro­vi­sion would've saved Medicare $26.5B from 2018 to 2020, JA­MA study says

3 years ago
Pharma

Ap­peals court toss­es J&J's con­tro­ver­sial 'Texas two-step' bank­rupt­cy case

3 years ago
Pharma
Law

Charles Riv­er se­cures $50M ac­qui­si­tion of drug dis­cov­ery tech com­pa­ny

3 years ago
Deals
Manufacturing

Or­a­cle ex­ec­u­tive Troy Tazbaz named new FDA di­rec­tor of dig­i­tal health

3 years ago
People
Pharma
First page Previous page 394395396397398399400 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times